Capricor Therapeutics (CAPR) Asset Utilization Ratio (2012 - 2025)
Capricor Therapeutics' (CAPR) quarterly Asset Utilization Ratio came in at 0.09 in Q3 2025, down 80.16% year-on-year from 0.43 in Q3 2024, and down 8.15% quarter-over-quarter from 0.09 in Q2 2025.
Capricor Therapeutics (CAPR) Asset Utilization Ratio (2012 - 2025) Analysis & Trends
Capricor Therapeutics' Asset Utilization Ratio history runs 14 years deep, the most recent figure standing at 0.09 for Q3 2025.
- On a quarterly basis, Asset Utilization Ratio fell 80.16% year-over-year to 0.09 in Q3 2025; TTM through Sep 2025 was 0.09, a 80.16% decrease from a year earlier, with the FY2024 full-year figure at 0.19, down 58.0% from the prior year.
- Asset Utilization Ratio slipped to 0.09 in Q3 2025 per CAPR's latest filing, from 0.09 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.74 in Q2 2024 and bottomed at 0.0 in Q1 2021.
- The 5-year median for Asset Utilization Ratio is 0.11 (2023), against an average of 0.21.
- Across the five-year window, Asset Utilization Ratio tumbled 94.4% in 2021 and jumped 970.54% in 2023, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.01 in 2021, then jumped by 745.62% to 0.05 in 2022, then soared by 970.54% to 0.53 in 2023, then sank by 60.44% to 0.21 in 2024, then plunged by 58.79% to 0.09 in 2025.
- Per Business Quant, the three latest CAPR Asset Utilization Ratio figures stand at 0.09 (Q3 2025), 0.09 (Q2 2025), and 0.11 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Capricor Therapeutics | 457.86 Mn | 457.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.09 |
| Jun 30, 2025 | 0.09 |
| Mar 31, 2025 | 0.11 |
| Dec 31, 2024 | 0.21 |
| Sep 30, 2024 | 0.43 |
| Jun 30, 2024 | 0.74 |
| Mar 31, 2024 | 0.60 |
| Dec 31, 2023 | 0.53 |
| Sep 30, 2023 | 0.34 |
| Jun 30, 2023 | 0.19 |
| Mar 31, 2023 | 0.11 |
| Dec 31, 2022 | 0.05 |
| Sep 30, 2022 | 0.03 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | 0.00 |
| Dec 31, 2020 | 0.01 |
| Sep 30, 2020 | 0.01 |
| Jun 30, 2020 | 0.02 |